Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Soenjoyo (Singapore, Singapore), N. Nadkarni (Singapore, Singapore), A. Fang (Singapore, Singapore), M. Koh (Singapore, Singapore). Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients. 4329

Member's Comments

No comment yet.

Related content which might interest you: Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Frequent exacerbators among patients with COPD - prevalence and stability Source: International Congress 2017 – Markers of COPD progression Year: 2017 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Frequent COPD exacerbators are not a stabile phenotype Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Comparison of small airways disease measures between frequent and infrequent COPD exacerbators Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Characteristics of "frequent exacerbators" in mild to moderate COPD patients. Source: International Congress 2018 – COPD around the world Year: 2018 Analysis of the causes for the frequent exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Bronchial Thermosplaty and severe asthma with frequent severe exacerbations : a controlled study. Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Difficult-to-treat and severe asthma Source: Breathe 2014; 10: 91-94 Year: 2014 The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations. Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016